Esomeprazole sodium enteric-coated tablet and preparation method thereof

A technology of esomeprazole sodium and enteric-coated tablets, which is applied in pill delivery, pharmaceutical formulations, medical preparations containing active ingredients, etc., can solve problems such as increasing gastrointestinal irritation and increasing operation complexity, and achieve increased drug use Safety, improved drug stability, improved release effect

Inactive Publication Date: 2013-04-03
QINGDAO UNIV
View PDF6 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the amount of alkaline regulator is less, surfactants are also added, which increases the irritation to the stomach
In addition, the raw materials also need to be micronized and coated with pellets, which increases the complexity of the operation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Esomeprazole sodium enteric-coated tablet and preparation method thereof
  • Esomeprazole sodium enteric-coated tablet and preparation method thereof
  • Esomeprazole sodium enteric-coated tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Tablet core prescription

[0027]

[0028] Barrier Formulation

[0029]

[0030] Enteric layer formula

[0031]

[0032] Preparation Process

[0033] Mix esomeprazole sodium with lactose, sodium carboxymethyl starch, and microcrystalline cellulose evenly, add aqueous sodium hydroxide solution, granulate, dry, add magnesium stearate, mix evenly, and compress to obtain the product.

[0034] The compressed tablet is coated with an isolation coat with a weight gain of 5%, and then with an enteric coating with a weight gain of 15%.

Embodiment 2

[0036] Tablet core prescription

[0037]

[0038] Barrier Formulation

[0039]

[0040] Enteric layer formula

[0041]

[0042] Preparation Process

[0043] Mix esomeprazole sodium, sodium carboxymethyl starch and microcrystalline cellulose evenly, add sodium carbonate aqueous solution, granulate, dry, add magnesium stearate, mix evenly, and tablet to obtain.

[0044] The compressed tablet was coated with an isolation coat with a weight gain of 6%, and then with an enteric coating with a weight gain of 18%.

Embodiment 3

[0046] Tablet core prescription

[0047]

[0048] Barrier Formulation

[0049]

[0050]

[0051] Enteric layer formula

[0052]

[0053] Preparation Process

[0054] Mix esomeprazole sodium with lactose and crospovidone evenly, add sodium hydroxide aqueous solution, granulate, dry, add magnesium stearate, mix evenly, and compress into tablets to obtain the product.

[0055] The compressed tablet is coated with an isolation coat with a weight gain of 5%, and then with an enteric coating with a weight gain of 15%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an esomeprazole sodium enteric-coated tablet, which is obtained by coating a tablet core with an isolation coating and an enteric coating in sequence. The tablet core is composed of esomeprazole sodium, sodium hydroxide, a filler, a disintegrating agent and a lubricating agent, wherein the weight ratio of the esomeprazole sodium to the sodium hydroxide is 1: (0.05-0.45). According to a preparation method, through dissolving an alkaline material in a solvent, the esomeprazole sodium and a pharmaceutic adjuvant mixture are used for granulating; not only is the addition amount of the alkaline material greatly reduced, but also consistency of an alkaline environment in the tablet core is guaranteed; and the stability of medicine is improved.

Description

Background technique [0001] Esomeprazole is the S-isomer of omeprazole, which has metabolic advantages. Compared with omeprazole, it has higher bioavailability and more consistent pharmacokinetics. Esomeprazole has been listed Magnesium oral preparation, the chemical name of its active ingredient is S-5-methoxy-2-{[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl}- 1H-Benzimidazole Magnesium, the structural formula is as follows: [0002] [0003] The raw material of esomeprazole magnesium has poor stability and poor water solubility, is easily destroyed in gastric acid, and is easily degraded when exposed to light. The raw material of esomeprazole sodium is less stable than esomeprazole magnesium, which is also the main reason why no esomeprazole sodium oral preparations have been listed in any country in the world so far. The prior art also only discloses the enteric-coated preparation of esomeprazole magnesium, such as: [0004] CN102100671A discloses a preparation m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/28A61K31/4439
Inventor 孙勇徐丽洒徐平刘巧囡袁海成
Owner QINGDAO UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap